Inspire Corporate Bond ETF (IBD): Biblically Responsible Fixed Income

Christians who want biblically responsible investing have been asking the same question for years. Sure, there are Christian equity funds. But what about bonds? The fixed income side of BRI has been weirdly underserved compared to the equity side.

Enter IBD, the Inspire Corporate Bond ETF. Launched in 2018, it's one of the only accessible biblically screened bond funds on the market. Let's actually look at what it does and whether it holds up against conventional corporate bond funds.

What IBD Actually Is

IBD is the Inspire Corporate Bond Impact ETF. It's an actively managed ETF that invests primarily in investment-grade US corporate bonds, with the twist that the underlying corporate issuers must meet Inspire's Impact Score thresholds.

That's an important distinction. IBD is not a passive index fund. It's an actively managed fund that uses Inspire's methodology to build a bond portfolio from issuers that pass biblical responsibility screens. The portfolio managers can make active decisions about duration, credit quality, sector allocation, and individual bond selection within the screened universe.

The Screening Logic

IBD screens the corporate issuers (the companies that issue the bonds), not the bonds themselves. A bond is a loan to a company, so if the company scores poorly on Inspire's criteria, its bonds don't make the fund.

The screening excludes companies involved in abortion, LGBTQ+ advocacy, adult entertainment, gambling, predatory lending, weapons of mass destruction, and other Inspire Impact Score factors. The same screens used for BIBL's equity side apply to IBD's bond issuers.

What you end up with is a portfolio of investment-grade corporate bonds issued by companies like Cintas, Caterpillar, Cummins, Parker Hannifin, Texas Instruments, Walmart, Berkshire Hathaway, and similar names that pass the Impact Score. Big banks are generally avoided, not because banking is problematic per se, but because many large banks have policies that score poorly on other Impact Score criteria.

Expense Ratio: 0.51 Percent

IBD charges 0.51 percent per year. That's significantly higher than vanilla corporate bond ETFs like LQD (iShares Investment Grade Corporate Bond ETF) at 0.14 percent or VCIT (Vanguard Intermediate-Term Corporate Bond) at 0.04 percent.

Is the premium justified? Active management plus faith-based screening costs more than passive market-cap weighting. But 0.51 percent eats into bond returns in a way it doesn't eat into equity returns. When your bond portfolio is yielding 5 percent, a 51 basis point fee is 10 percent of your gross yield. That's painful.

AUM: Around 80 to 100 Million Dollars

IBD is small. Assets are approximately 80 to 100 million dollars as of early 2026. That's tiny for a bond ETF. For context, LQD has over 30 billion dollars. VCIT has over 50 billion.

Why so small? Two reasons. First, Christian investors have historically been slower to adopt fixed income BRI products because the category is newer. Second, the higher expense ratio makes IBD a harder sell against the massive conventional alternatives.

Small AUM matters more for bond ETFs than equity ETFs because bond liquidity is inherently tighter. IBD's bid-ask spreads can be meaningful (5 to 15 cents typically), which adds transaction friction.

What's Inside the Portfolio

IBD typically holds 150 to 200 individual corporate bonds. The fund targets an average credit quality of investment grade (BBB or higher), with the bulk of holdings in the A to BBB range. Average duration runs around 6 to 8 years, which puts it in the intermediate-term category similar to LQD.

Sector exposure is roughly: 25 to 30 percent industrials, 15 to 20 percent consumer-related issuers, 12 to 16 percent healthcare, 10 to 14 percent technology, 8 to 12 percent energy and utilities, and smaller slices elsewhere. Financial sector weight is notably lower than LQD, which is about 30 percent banks and insurers, because many big financial issuers don't pass Impact Score screening.

Yield and Distributions

IBD distributes monthly, which is standard for bond ETFs. Current 30-day SEC yield is approximately 4.2 to 4.8 percent in the current rate environment, depending on when you measure.

That yield is reasonably competitive with LQD (typically 4.5 to 5.0 percent 30-day SEC yield). The gap is mostly the expense ratio difference. A 0.37 percent expense differential between IBD and LQD comes straight out of yield.

Performance Estimates

Bond ETF performance is largely a function of duration and credit spreads, so IBD tracks reasonably close to conventional intermediate corporate bond ETFs with small differences from sector mix.

One-year total return: approximately 4 to 7 percent. Bonds had a mixed year in 2025 with rates volatile.

Three-year annualized: approximately 1 to 3 percent. The 2022 rate shock hurt all intermediate corporate bond funds including IBD.

Five-year annualized: approximately 1 to 3 percent. Same story.

Since inception (July 2018): approximately 2 to 4 percent annualized. Roughly in line with LQD over the same period, with occasional divergence based on sector weights.

Comparison to LQD

LQD is the obvious benchmark. Let me give you the honest side-by-side.

Expense ratio: IBD 0.51, LQD 0.14. Advantage LQD by 37 basis points per year.

Yield: IBD about 4.5, LQD about 4.8. Advantage LQD by roughly 30 basis points, mostly due to expense ratio differential.

AUM: IBD 90 million, LQD 30 billion plus. LQD obviously much larger.

Spreads: IBD wider than LQD due to lower trading volume.

Screening: IBD has Inspire's biblical responsibility screens, LQD has none.

If you don't care about biblical screening, LQD wins on every dimension. If biblical screening matters to you, the question is whether paying 37 basis points extra per year is worth the peace of mind. Over 10 years on a 100,000 dollar position, that's roughly 4,000 dollars in fees foregone.

The Intent Problem

Here's something worth sitting with. Corporate bonds are, by their nature, a form of interest-bearing debt. Some Christians (and most observant Muslims) would argue that the entire corporate bond asset class is problematic because of the interest component itself, regardless of which companies issue the bonds.

Inspire's approach treats biblical responsibility as a question of who you lend to, not whether lending with interest is itself acceptable. That's a mainstream Christian position and it's theologically defensible, but it's worth being aware that BRI's approach differs fundamentally from Islamic finance in this regard. Muslims who want halal fixed income have to use sukuk funds instead of screened corporate bond funds.

If you're a Christian who's comfortable with corporate bonds in principle and just wants to avoid lending to companies whose business practices conflict with your values, IBD does the job. If you have theological concerns about interest itself, IBD won't solve that.

Distribution Schedule

IBD pays monthly distributions, typically on the last business day of the month. Monthly payouts are useful for retirees who want income for living expenses and for dollar-cost averagers who want frequent reinvestment opportunities.

Who IBD Makes Sense For

Christian investors who want fixed income exposure with biblical responsibility screening and are willing to pay a modest expense ratio premium for that. Retirees who need intermediate-duration corporate bond exposure and want to align their fixed income with their values. Advisors running BRI model portfolios who need a plug-and-play corporate bond sleeve.

Who Should Look Elsewhere

Cost-sensitive investors who consider the 37 basis point premium over LQD too steep. Investors who want broader bond diversification (IBD is US corporate only, no treasuries, no munis, no international). Anyone who wants a Treasury-heavy safe-haven bond allocation (IBD doesn't hold government bonds).

Other BRI Fixed Income Options

Inspire also has RISN (a momentum-based fund, not fixed income) and some separately managed accounts. Outside of Inspire, Praxis Mutual Funds offers the Praxis Impact Bond Fund (MIIAX), which is another biblically screened fixed income option, though it's structured as a mutual fund rather than an ETF. GuideStone (affiliated with the Southern Baptist Convention) offers several screened bond fund options for institutional investors.

For most retail Christian investors, IBD is the easiest single-ticker option to buy in a brokerage account.

Bottom Line

IBD is a legitimate biblically responsible corporate bond ETF that does the job it's designed to do. It's not the cheapest bond fund you can buy, and the AUM is small enough that trading friction matters, but for a Christian investor who wants their entire portfolio (stocks and bonds) to align with their values, IBD fills a real gap.

The honest trade-off is that you're paying about 37 basis points per year in extra expense ratio for the screening, plus accepting wider bid-ask spreads and smaller AUM. If that cost is worth it to you, IBD does its job. If not, LQD plus a clean conscience about how conventional corporate bond funds work might be the pragmatic answer.